Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetramethylammonium Ion SCHEMBL11226372 | 1.00 | CHRNB2 (0.33) | CHRNB2CHRNA7CHRNA4SLC34A1 | |
| Tetramethylammonium Ion SCHEMBL10181373 | 0.92 | CHRNB2 (0.33) | CHRNB2CHRNA7CHRNA4SLC34A1 | |
| Tetramethylammonium Ion SCHEMBL545336 | 0.82 | CHRNB2 (0.40) | CHRNB2CHRNA7CHRNA4SLC34A1 | |
| Tetramethylammonium Ion SCHEMBL1130116 | 0.82 | SLC34A1 (0.41) | SLC34A1 | |
| Tetramethylammonium Ion SCHEMBL15924284 | 0.78 | CHRNB2 (0.36) | CHRNB2CHRNA7CHRNA4SLC34A1 | |
| Tetramethylammonium Ion SCHEMBL7641461 | 0.78 | CHRNB2 (0.36) | CHRNB2CHRNA7CHRNA4SLC34A1 | |
| Tetramethylammonium Ion SCHEMBL1204834 | 0.78 | CHRNB2 (0.36) | CHRNB2CHRNA7CHRNA4SLC34A1 | |
| SCHEMBL23037338 | 0.77 | SLC34A1 (0.39) | SLC34A1 | |
| SCHEMBL23037334 | 0.77 | SLC34A1 (0.39) | SLC34A1 | |
| Silver SCHEMBL20593984 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114269884-A | Improved formulations for high selectivity silicon nitride etching | 恩特格里斯公司 | 2022-04-01 | — | — | CN | claimed |
| CN-117143592-B | Mn (Mn)4+Activated fluoride (oxide) red fluorescent material and preparation method thereof | 华南理工大学 | 2026-05-22 | — | — | CN | disclosed |
| CN-117143592-A | Mn (Mn) 4+ Activated fluoride (oxide) red fluorescent material and preparation method thereof | 华南理工大学 | 2023-12-01 | — | — | CN | disclosed |
| EP-2830143-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEM CORP (JP) | 2019-05-22 | — | — | EP | disclosed |
| US-10056646-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2018-08-21 | — | — | US | disclosed |
| US-9780409-B2 | Nonaqueous electrolytic solution and nonaqueous-electrolyte battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| EP-2830143-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE CELL | Mitsubishi Chemical Corporation (JP) | 2015-01-28 | — | — | EP | disclosed |
| US-20150024284-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-01-22 | — | — | US | disclosed |
| US-20150004481-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-01-01 | — | — | US | disclosed |
| US-20130337317-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION, AND BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20130244122-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | ONUKI MASAMICHI (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20120219866-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-08-30 | — | — | US | disclosed |
| EP-2475041-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE BATTERY COMPRISING SAME | Mitsubishi Chemical Corporation (JP) | 2012-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150024284-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | TREH, SLC6A12, SCNN1G | CHRNB2 3597/4885CHRNA7 3547/4885CHRNA4 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.